IL147920A0 - Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants - Google Patents
Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plantsInfo
- Publication number
- IL147920A0 IL147920A0 IL14792000A IL14792000A IL147920A0 IL 147920 A0 IL147920 A0 IL 147920A0 IL 14792000 A IL14792000 A IL 14792000A IL 14792000 A IL14792000 A IL 14792000A IL 147920 A0 IL147920 A0 IL 147920A0
- Authority
- IL
- Israel
- Prior art keywords
- cgmmv
- resistant plants
- generating
- genetic constructs
- plants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99202540 | 1999-08-02 | ||
| PCT/NL2000/000534 WO2001009300A2 (en) | 1999-08-02 | 2000-07-27 | Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147920A0 true IL147920A0 (en) | 2002-08-14 |
Family
ID=8240518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14792000A IL147920A0 (en) | 1999-08-02 | 2000-07-27 | Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1198572A2 (en) |
| AU (1) | AU6322900A (en) |
| IL (1) | IL147920A0 (en) |
| WO (1) | WO2001009300A2 (en) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459604B2 (en) | 2001-02-08 | 2008-12-02 | Keygene N.V. | Methods for generating resistance against CGMMV in plants |
| US8393001B1 (en) | 2002-07-26 | 2013-03-05 | Mcafee, Inc. | Secure signature server system and associated method |
| ES2528631T3 (en) | 2003-04-08 | 2015-02-11 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
| ZA200607843B (en) * | 2004-02-23 | 2008-06-25 | Israel State | Engrafted plants resistant to viral diseases and methods of producing same |
| WO2006079372A1 (en) | 2005-01-31 | 2006-08-03 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
| JP5047950B2 (en) | 2005-05-18 | 2012-10-10 | アブリンクス エン．ヴェー． | Improved Nanobody ™ for tumor necrosis factor-alpha |
| ES2852423T3 (en) | 2005-05-20 | 2021-09-13 | Ablynx Nv | Enhanced NanobodiesTM for the Treatment of Aggregation-Mediated Disorders |
| EP2557090A3 (en) | 2006-12-19 | 2013-05-29 | Ablynx N.V. | Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| US9156914B2 (en) | 2006-12-19 | 2015-10-13 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
| JP5266489B2 (en) * | 2007-03-14 | 2013-08-21 | 国立大学法人愛媛大学 | Gene silencing suppression technology |
| CN102942572A (en) | 2007-03-29 | 2013-02-27 | 普罗热尼奇制药公司 | Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof |
| AU2008328781A1 (en) | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| US8766041B2 (en) | 2008-01-10 | 2014-07-01 | Enza Zaden Beheer B.V. | Marker genetically linked to tobamovirus resistance in cucumber and the use thereof |
| KR101581480B1 (en) | 2008-02-06 | 2015-12-30 | 프로제닉스 파머슈티컬스, 인코포레이티드 | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
| US20110091462A1 (en) | 2008-03-05 | 2011-04-21 | Ablynx N.V. | Novel antigen binding dimer-complexes, methods of making and uses thereof |
| EP2260058A2 (en) | 2008-04-07 | 2010-12-15 | Ablynx N.V. | Single variable domains against the notch pathways |
| US8217140B2 (en) | 2008-04-17 | 2012-07-10 | Ablynx N.V. | Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
| WO2010100135A1 (en) | 2009-03-05 | 2010-09-10 | Ablynx N.V. | Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
| RU2539798C2 (en) | 2009-04-10 | 2015-01-27 | Аблинкс Нв | Improved amino acid sequences against il-6r and polypeptides which contain thereof for treatment of il-6r associated diseases and disorders |
| CN105061592A (en) | 2009-06-05 | 2015-11-18 | 埃博灵克斯股份有限公司 | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| WO2011040978A2 (en) | 2009-10-02 | 2011-04-07 | Ludwig Institute For Cancer Research Ltd. | Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| EP2507262A1 (en) | 2009-11-30 | 2012-10-10 | Ablynx N.V. | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| WO2011095545A1 (en) | 2010-02-05 | 2011-08-11 | Ablynx Nv | Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same |
| SG189981A1 (en) | 2010-11-08 | 2013-06-28 | Novartis Ag | Cxcr2 binding polypeptides |
| CN104271598A (en) | 2011-06-23 | 2015-01-07 | 埃博灵克斯股份有限公司 | Immunoglobulin single variable domains directed against IgE |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| WO2014087010A1 (en) | 2012-12-07 | 2014-06-12 | Ablynx N.V. | IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE |
| NL1040254C2 (en) | 2013-05-17 | 2014-11-24 | Ablynx Nv | Stable formulations of immunoglobulin single variable domains and uses thereof. |
| NL2013007B1 (en) | 2014-06-16 | 2016-07-05 | Ablynx Nv | Methods of treating TTP with immunoglobulin single variable domains and uses thereof. |
| NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
| US10501541B2 (en) | 2015-01-27 | 2019-12-10 | Lava Therapeutics B.V. | Single domain antibodies targeting CD1d |
| EP3932945A1 (en) | 2015-11-27 | 2022-01-05 | Ablynx NV | Polypeptides inhibiting cd40l |
| EP3512880A1 (en) | 2016-09-15 | 2019-07-24 | Ablynx NV | Immunoglobulin single variable domains directed against macrophage migration inhibitory factor |
| US11840569B2 (en) | 2016-11-16 | 2023-12-12 | Ablynx N.V. | T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta |
| WO2018220225A1 (en) | 2017-06-02 | 2018-12-06 | Ablynx Nv | Aggrecan binding immunoglobulins |
| CA3064318A1 (en) | 2017-06-02 | 2018-12-06 | Merck Patent Gmbh | Polypeptides binding adamts5, mmp13 and aggrecan |
| BR112019025097A2 (en) | 2017-06-02 | 2020-07-28 | Merck Patent Gmbh | mmp13-binding immunoglobulins |
| KR20200012935A (en) | 2017-06-02 | 2020-02-05 | 메르크 파텐트 게엠베하 | ADAMTS binding immunoglobulins |
| CN107860774B (en) * | 2017-11-10 | 2020-01-07 | 青岛市农业科学研究院 | Screening method of sensitive genotype of agrobacterium tumefaciens of cucumber |
| SG11202006902QA (en) | 2018-02-06 | 2020-08-28 | Ablynx Nv | Methods of treating initial episode of ttp with immunoglobulin single variable domains |
| US20220143204A1 (en) | 2019-03-08 | 2022-05-12 | Linxis B.V. | Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation |
| WO2020245663A1 (en) | 2019-06-01 | 2020-12-10 | Institut Pasteur | Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection |
| WO2022060223A1 (en) | 2020-09-16 | 2022-03-24 | Linxis B.V. | Internalizing binding molecules |
| EP4019548A1 (en) | 2020-12-23 | 2022-06-29 | Vrije Universiteit Brussel | Anti lag3 vhhs and their use |
| CN112920262B (en) * | 2021-02-03 | 2022-09-16 | 浙江省农业科学院 | Protein ClALKBH2B capable of inhibiting CGMMV accumulation, gene, expression vector, transformant and method thereof |
| CN115433733A (en) | 2021-06-04 | 2022-12-06 | 生物岛实验室 | Cyclic RNA (ribonucleic acid) Circ-ACE2 translated polypeptide and application thereof |
| WO2023068382A2 (en) | 2021-10-20 | 2023-04-27 | Takeda Pharmaceutical Company Limited | Compositions targeting bcma and methods of use thereof |
| CN114107371B (en) * | 2021-12-06 | 2024-03-29 | 中国农业科学院郑州果树研究所 | Cucumber green mottle mosaic virus gene mediated transgenic tobacco method |
| CN116837004A (en) * | 2021-12-06 | 2023-10-03 | 中国农业科学院郑州果树研究所 | Chimeric structure IMC and application thereof in cucumber green mottle mosaic virus resistant tobacco cultivation |
| WO2024023271A1 (en) | 2022-07-27 | 2024-02-01 | Ablynx Nv | Polypeptides binding to a specific epitope of the neonatal fc receptor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2078134A1 (en) * | 1990-03-12 | 1991-09-13 | Milton Zaitlin | Transformation of plants with non-structural plant virus gene sequences |
| GB9208545D0 (en) * | 1992-04-21 | 1992-06-03 | Gatsby Charitable Foundation T | Virus resistant plants |
-
2000
- 2000-07-27 AU AU63229/00A patent/AU6322900A/en not_active Abandoned
- 2000-07-27 EP EP00950079A patent/EP1198572A2/en not_active Withdrawn
- 2000-07-27 WO PCT/NL2000/000534 patent/WO2001009300A2/en not_active Application Discontinuation
- 2000-07-27 IL IL14792000A patent/IL147920A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001009300A3 (en) | 2001-08-23 |
| EP1198572A2 (en) | 2002-04-24 |
| WO2001009300A2 (en) | 2001-02-08 |
| AU6322900A (en) | 2001-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147920A0 (en) | Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants | |
| PT2944695T (en) | Novel plant expression constructs | |
| HUP0102998A3 (en) | Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch | |
| MXPA01010930A (en) | Herbicide resistant plants. | |
| ZA200202843B (en) | Method for improving growth. | |
| HUP0104914A3 (en) | Galenicformulations fast disintegrating the mouth and method for preparing same | |
| HUP0200926A2 (en) | Plant transformation method | |
| MX257801B (en) | Plant transformation methods | |
| MXPA02003232A (en) | Compositions and methods for altering gene expression. | |
| ZA200109348B (en) | Noninvasive genetic immunization, expression products therefrom, and uses thereof. | |
| ZA994522B (en) | Coating plant. | |
| EP1160192A4 (en) | Micromanipulation method | |
| ZA9711103B (en) | Plant support. | |
| HUP0200144A3 (en) | Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates | |
| EP1144608A3 (en) | Synthetic vectors, transgenic plants containing them, and methods for obtaining them | |
| ZA200002546B (en) | Sorbate-preserved compositions, method for the manufacture thereof and their use. | |
| GB0029720D0 (en) | I.S machine7544232001 | |
| MXPA03009145A (en) | Plant invigorator. | |
| IL146573A0 (en) | Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones | |
| EP1206524A4 (en) | Methods for generating doubled haploid plants | |
| GB9917109D0 (en) | Plant genes | |
| HK1047679A1 (en) | Method for constructing virus-free plant. | |
| ZA200109201B (en) | Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants. | |
| HK1031881A1 (en) | Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein. | |
| MXPA03001493A (en) | Pseudomycins useful against plant diseases. |